NDC 72511-750 – Repatha

Evolocumab 140 mg/mL · Injection, Solution · Subcutaneous

Human Prescription Drug

Product NDC72511-750

Product details

Brand name
Repatha
Generic name
Evolocumab
Labeler
Amgen USA Inc.
Dosage form
Injection, Solution
Route
Subcutaneous
Marketing category
BLA · BLA125522
Marketed since
October 9, 2018
Listing expires
December 31, 2027
Pharmacologic class
PCSK9 Inhibitor

Active ingredients

Uses, dosage, side effects and warnings for Repatha →

Package NDC codes (1)

Package NDCDescriptionSince
72511-750-011 SYRINGE in 1 CARTON (72511-750-01) / 1 mL in 1 SYRINGEOct 9, 2018

Other Repatha products